Leptin gene (TTTC)n microsatellite polymorphism as well as leptin receptor R223Q and PPAR2 P12A substitutions are not associated with hypertensive disorders in pregnancy

American Journal of Reproductive Immunology

Volumn 63, Issue 4, 2010, Pages 310-317

  Wiedemann, Annette ^a   Vocke, Franziska ^a   Fitzgerald, Justine S ^b   Markert, Udo R ^b   Jeschke, Udo ^c   Lohse, Peter ^a   Toth, Bettina ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hypertensive disorders in pregnancy; Leptin gene; Leptin receptor; Polymorphism

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; MICROSATELLITE DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECLAMPSIA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HELLP SYNDROME; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NUCLEOTIDE REPEAT; PREECLAMPSIA; PRIORITY JOURNAL; TETRANUCLEOTIDE REPEAT; WILD TYPE; BLOOD PRESSURE; CASE CONTROL STUDY; GENETICS; PATHOPHYSIOLOGY; PREGNANCY; RETROSPECTIVE STUDY;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LEPTIN; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; PPAR GAMMA; PREGNANCY; RECEPTORS, LEPTIN; RETROSPECTIVE STUDIES;

EID: 77951245020     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00799.x     Document Type: Article

References (45)

1. Durig P, Ferrier C, Schneider H. Hypertensive disorders in pregnancy. Ther Umsch 1999, 56:561-571.
2. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986, 155:501-509.
3. Villar MA, Sibai BM. Eclampsia. Obstet Gynecol Clin North Am 1988, 15:355-377.
4. Adukauskiene D, Vizgirdaite V, Rimaitis K, Aliuskeviciene A. Hemolysis, elevated liver enzymes, and low platelet count syndrome. Medicina (Kaunas) 2006, 42:695-702.
5. Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet 2003, 64:96-103.
6. Kadyrov M, Schmitz C, Black S, Kaufmann P, Huppertz B. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta 2003, 24:540-548.
7. Starzyk KA, Pijnenborg R, Salafia CM. Decidual and vascular pathophysiology in pregnancy compromise. Semin Reprod Endocrinol 1999, 17:63-72.
8. Käär K, Jouppila P, Kuikka J, Luotola H, Toivanen J, Rekonen A. Intervillous blood flow in normal and complicated late pregnancy measured by means of an intravenous 133Xe method. Acta Obstet Gynecol Scand 1980, 59:7-10.
9. Sargent IL, Borzychowski AM, Redman CW. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online 2006, 13:680-686.
10. Muy-Rivera M, Ning Y, Frederic IO, vadachkoria S, Luthy DA, Williams MA. Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk. Physiol Res 2005, 54:167-174.
11. Waite LL, Louie RE, Taylor RN. Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab 2005, 90:620-626.
12. Henson MC, Castracane VD. Leptin in pregnancy: an update. Biol Reprod 2006, 74:218-229.
13. Anim-Nyame N, Sooranna SR, Steer PJ, Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 2000, 15:2033-2036.
14. Beltowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006, 24:789-801.
15. Henson MC, Swan KF, O'Neil JS. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet Gynecol 1998, 92:1020-1028.
16. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002, 51:2341-2347.
17. Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 2005, 146:3334-3342.
18. Toth B, Bastug M, Scholz C, Arck P, Schulze S, Kunze S, Friese K, Jeschke U. Leptin and peroxisome proliferator-activated receptors: impact on normal and disturbed first trimester human pregnancy. Histol Histopathol 2008, 23:1465-1475.
19. Toth B, Bastug M, Mylonas I, Scholz C, Makovitzky J, Kunze S, Thaler C, Friese K, Jeschke U. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage. Acta Histochem 2009, 111:372-378.
20. Fournier T, Tsatsaris V, Handschuh K, Evain-Brion D. PPARs and the placenta. Placenta 2007, 28:65-76.
21. Stefański A, Majkowska L, Ciechanowicz A, Frankow M, Safranow K, Parczewski M, Moleda P, Pilarska K. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes. J Hum Hypertens 2006, 20:684-692.
22. Toth B, Hornung D, Scholz C, Djalali S, Friese K, Jeschke U. Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am J Reprod Immunol 2007, 58:289-310.
23. Hinuy HM, Hirata MH, Sampaio MF, Armaganijan D, Salazar LA, Hirata RD. LEP 3′HVR is associated with obesity and leptin levels in Brazilian individuals. Mol Genet Metab 2006, 89:374-380.
24. Shintani M, Ikegami H, Fujisawa T, Kawaguchi Y, Ohishi M, Katsuya T, Higaki J, Shimamoto K, Ogihara T. Leptin gene polymorphism is associated with hypertension independent of obesity. J Clin Endocrinol Metab 2002, 87:2909-2912.
25. Rosmond R, Chagnon YC, Holm G, Chagnon M, Pérusse L, Lindell K, Carlsson B, Bouchard C, Björntorp P. Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000, 85:3126-3131.
26. Rigó J, Szendei G, Rosta K, Fekete A, Bögi K, Molvarec A, Rónai Z, Vér A. Leptin receptor gene polymorphisms in severely pre-eclamptic women. Gynecol Endocrinol 2006, 22:521-525.
27. Nagy B, Varkonyi T, Molvarec A, Lazar L, Hupuczi P, Than NG, Rigo J. Leptin gene (TTTC)(n) microsatellite polymorphism in pre-eclampsia and HELLP syndrome. Clin Chem Lab Med 2009, 47:1033-1037.
28. Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005, 46:1077-1085.
29. Sane DC, Anton L, Brosnihan KB. Angiogenic growth factors and hypertension. Angiogenesis 2004, 7:193-201.
30. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997, 37:240-249.
31. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, martin JN, Bennett WA. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999, 181:915-920.
32. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996, 32:157-169.
33. Tarrade A, Schoonjans K, Pavan L, Auwerx J, Rochette-Egly C, Evan-brion D, Fournier T. PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 2001, 86:5017-5024.
34. Machinal F, Dieudonne MN, Leneveu MC, Pecqeury R, Giucdicelli Y. In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 1999, 140:1567-1574.
35. O'Neil JS, Burow ME, Green AE, McLachlan JA, Henson MC. Effects of estrogen on leptin gene promoter activation in MCF-7 breast cancer and JEG-3 choriocarcinoma cells: selective regulation via estrogen receptors alpha and beta. Mol Cell Endocrinol 2001, 176:67-75.
36. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997, 3:1029-1033.
37. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones OS, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002, 187:127-136.
38. Teppa RJ, Ness RB, Crombleholme WR, Roberts JM. Free leptin is increased in normal pregnancy and further increased in preeclampsia. Metabolism 2000, 49:1043-1048.
39. Lolmède K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumié A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord 2003, 27:1187-1195.
40. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
41. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 2003, 100:6712-6717.
42. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000, 49:497-505.
43. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 1996, 98:1004-1009.
44. Kallen CB, Lazar MA. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 1996, 93:5793-5796.
45. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998, 20:284-287.